Increased carotid intima-media thickness in pediatric nephrotic syndrome: A meta-analysis

Yongzheng Zhang1, Mingda Song1, Hai Wang1

  • 1The Second Department of Pediatrics, the First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Biomolecules & Biomedicine
|September 18, 2025
PubMed

Insights

Children with nephrotic syndrome (NS) show increased carotid intima-media thickness (cIMT), indicating early atherosclerosis. Male predominance and steroid-resistant NS may influence these vascular changes in pediatric patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health
  • Vascular Biology

Background:

  • Nephrotic syndrome (NS) in children is linked to heightened atherosclerosis risk, evidenced by carotid intima-media thickness (cIMT).
  • Existing research on NS and pediatric cIMT shows inconsistent findings, necessitating further investigation.
  • Early detection of vascular changes in pediatric NS is crucial for long-term health management.

Purpose of the Study:

  • To systematically compare cIMT measurements between pediatric patients with NS and healthy controls.
  • To identify factors contributing to heterogeneity in cIMT findings across studies.
  • To elucidate the relationship between NS and subclinical atherosclerosis in children.

Main Methods:

  • A meta-analysis of thirteen observational case-control studies was performed.
  • Data from 578 children with NS and 741 controls were aggregated using a random-effects model.
  • Searches were conducted in PubMed, Embase, and Web of Science up to May 22, 2025.

Main Results:

  • Children with NS exhibited significantly higher cIMT than controls (Mean Difference: 0.06 mm; 95% CI: 0.04-0.08).
  • Subgroup analysis showed a greater cIMT difference in studies with a higher proportion of male participants.
  • No significant differences in cIMT were found based on age, disease duration, or adjustments for BMI, blood pressure, or lipids.

Conclusions:

  • Pediatric nephrotic syndrome is associated with increased carotid intima-media thickness, suggesting accelerated vascular changes.
  • The proportion of males and the prevalence of steroid-resistant nephrotic syndrome (SRNS) may contribute to observed heterogeneity.
  • These findings highlight the importance of monitoring cardiovascular risk in children with NS.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
504
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
203
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
282
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344